Cargando…
Complement inhibition decreases early fibrogenic events in the lung of septic baboons
Acute respiratory distress syndrome (ARDS) induced by severe sepsis can trigger persistent inflammation and fibrosis. We have shown that experimental sepsis in baboons recapitulates ARDS progression in humans, including chronic inflammation and long-lasting fibrosis in the lung. Complement activatio...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627561/ https://www.ncbi.nlm.nih.gov/pubmed/26337158 http://dx.doi.org/10.1111/jcmm.12667 |
_version_ | 1782398300432891904 |
---|---|
author | Silasi-Mansat, Robert Zhu, Hua Georgescu, Constantin Popescu, Narcis Keshari, Ravi S Peer, Glenn Lupu, Cristina Taylor, Fletcher B Pereira, Heloise Anne Kinasewitz, Gary Lambris, John D Lupu, Florea |
author_facet | Silasi-Mansat, Robert Zhu, Hua Georgescu, Constantin Popescu, Narcis Keshari, Ravi S Peer, Glenn Lupu, Cristina Taylor, Fletcher B Pereira, Heloise Anne Kinasewitz, Gary Lambris, John D Lupu, Florea |
author_sort | Silasi-Mansat, Robert |
collection | PubMed |
description | Acute respiratory distress syndrome (ARDS) induced by severe sepsis can trigger persistent inflammation and fibrosis. We have shown that experimental sepsis in baboons recapitulates ARDS progression in humans, including chronic inflammation and long-lasting fibrosis in the lung. Complement activation products may contribute to the fibroproliferative response, suggesting that complement inhibitors are potential therapeutic agents. We have been suggested that treatment of septic baboons with compstatin, a C3 convertase inhibitor protects against ARDS-induced fibroproliferation. Baboons challenged with 10(9) cfu/kg (LD50) live E. coli by intravenous infusion were treated or not with compstatin at the time of challenge or 5 hrs thereafter. Changes in the fibroproliferative response at 24 hrs post-challenge were analysed at both transcript and protein levels. Gene expression analysis showed that sepsis induced fibrotic responses in the lung as early as 24 hrs post-bacterial challenge. Immunochemical and biochemical analysis revealed enhanced collagen synthesis, induction of profibrotic factors and increased cell recruitment and proliferation. Specific inhibition of complement with compstatin down-regulated sepsis-induced fibrosis genes, including transforming growth factor-beta (TGF-β), connective tissue growth factor (CTGF), tissue inhibitor of metalloproteinase 1 (TIMP1), various collagens and chemokines responsible for fibrocyte recruitment (e.g. chemokine (C-C motif) ligand 2 (CCL2) and 12 (CCL12)). Compstatin decreased the accumulation of myofibroblasts and proliferating cells, reduced the production of fibrosis mediators (TGF-β, phospho-Smad-2 and CTGF) and inhibited collagen deposition. Our data demonstrate that complement inhibition effectively attenuates collagen deposition and fibrotic responses in the lung after severe sepsis. Inhibiting complement could prove an attractive strategy for preventing sepsis-induced fibrosis of the lung. |
format | Online Article Text |
id | pubmed-4627561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-46275612015-11-05 Complement inhibition decreases early fibrogenic events in the lung of septic baboons Silasi-Mansat, Robert Zhu, Hua Georgescu, Constantin Popescu, Narcis Keshari, Ravi S Peer, Glenn Lupu, Cristina Taylor, Fletcher B Pereira, Heloise Anne Kinasewitz, Gary Lambris, John D Lupu, Florea J Cell Mol Med Original Articles Acute respiratory distress syndrome (ARDS) induced by severe sepsis can trigger persistent inflammation and fibrosis. We have shown that experimental sepsis in baboons recapitulates ARDS progression in humans, including chronic inflammation and long-lasting fibrosis in the lung. Complement activation products may contribute to the fibroproliferative response, suggesting that complement inhibitors are potential therapeutic agents. We have been suggested that treatment of septic baboons with compstatin, a C3 convertase inhibitor protects against ARDS-induced fibroproliferation. Baboons challenged with 10(9) cfu/kg (LD50) live E. coli by intravenous infusion were treated or not with compstatin at the time of challenge or 5 hrs thereafter. Changes in the fibroproliferative response at 24 hrs post-challenge were analysed at both transcript and protein levels. Gene expression analysis showed that sepsis induced fibrotic responses in the lung as early as 24 hrs post-bacterial challenge. Immunochemical and biochemical analysis revealed enhanced collagen synthesis, induction of profibrotic factors and increased cell recruitment and proliferation. Specific inhibition of complement with compstatin down-regulated sepsis-induced fibrosis genes, including transforming growth factor-beta (TGF-β), connective tissue growth factor (CTGF), tissue inhibitor of metalloproteinase 1 (TIMP1), various collagens and chemokines responsible for fibrocyte recruitment (e.g. chemokine (C-C motif) ligand 2 (CCL2) and 12 (CCL12)). Compstatin decreased the accumulation of myofibroblasts and proliferating cells, reduced the production of fibrosis mediators (TGF-β, phospho-Smad-2 and CTGF) and inhibited collagen deposition. Our data demonstrate that complement inhibition effectively attenuates collagen deposition and fibrotic responses in the lung after severe sepsis. Inhibiting complement could prove an attractive strategy for preventing sepsis-induced fibrosis of the lung. John Wiley & Sons, Ltd 2015-11 2015-09-03 /pmc/articles/PMC4627561/ /pubmed/26337158 http://dx.doi.org/10.1111/jcmm.12667 Text en © 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Silasi-Mansat, Robert Zhu, Hua Georgescu, Constantin Popescu, Narcis Keshari, Ravi S Peer, Glenn Lupu, Cristina Taylor, Fletcher B Pereira, Heloise Anne Kinasewitz, Gary Lambris, John D Lupu, Florea Complement inhibition decreases early fibrogenic events in the lung of septic baboons |
title | Complement inhibition decreases early fibrogenic events in the lung of septic baboons |
title_full | Complement inhibition decreases early fibrogenic events in the lung of septic baboons |
title_fullStr | Complement inhibition decreases early fibrogenic events in the lung of septic baboons |
title_full_unstemmed | Complement inhibition decreases early fibrogenic events in the lung of septic baboons |
title_short | Complement inhibition decreases early fibrogenic events in the lung of septic baboons |
title_sort | complement inhibition decreases early fibrogenic events in the lung of septic baboons |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627561/ https://www.ncbi.nlm.nih.gov/pubmed/26337158 http://dx.doi.org/10.1111/jcmm.12667 |
work_keys_str_mv | AT silasimansatrobert complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT zhuhua complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT georgescuconstantin complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT popescunarcis complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT keshariravis complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT peerglenn complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT lupucristina complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT taylorfletcherb complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT pereiraheloiseanne complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT kinasewitzgary complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT lambrisjohnd complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons AT lupuflorea complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons |